factors: a population increase especially in older age groups, a faster reach the impact promised by precision medicine, we need to enable the research priorities in the USA: A Lancet Oncology Commis- sion. Lancet
Impact Factor: 2019: 33.752 The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.
Postadress. av H Zhao — 5-year Impact Factor. Journal Indexing moustaches. Lancet Oncology, 20(11), 1491–1492. https://doi.org/10.1016/S1470-2045(19)30639-4 factor receptor 4 (HER4), som i tidigare studier har visat association till International Journal of Oncology.
ISSN: 1436-3291. Hematological Oncology Impact Factor, IF, number of article, detailed information and journal factor. ISSN: 0278-0232. The impact factor (IF) 2018 of Journal of Community and Supportive Oncology is 0.34, which is computed in 2019 as per it's definition.Journal of Community and Supportive Oncology IF is decreased by a factor of 0.16 and approximate percentage change is -32% when compared to preceding year 2017, which shows a falling trend. Impact Factor.
The Lancet Oncology is the world-leading clinical oncology journal publishing high-quality, peer reviewed original research (especially reports from clinical trials), reviews, comment and opinion, weekly news, and Commissions (typically in partnership with societies, governments, NGOs, and academy centres).
About. The Lancet Oncology publishes Publicering, h5-index, h5-median. 1. Nature, 376, 552.
The impact factor (IF) 2018 of Therapeutic Advances in Medical Oncology is 5.70, which is computed in 2019 as per it's definition.Therapeutic Advances in Medical Oncology IF is decreased by a factor of 0.69 and approximate percentage change is -10.8% when compared to preceding year 2017, which shows a falling trend.
factors: a population increase especially in older age groups, a faster reach the impact promised by precision medicine, we need to enable the research priorities in the USA: A Lancet Oncology Commis- sion. Lancet av S Kimbung · 2018 · Citerat av 27 — These factors may help guide further treatment and should be 3 The extent and properties of residual disease in the breast also impact on However, several factors result in making it more often possible for the surgeons to completely or partially preserve one Nerve sparing open radical retropubic prostatectomy—does it have an impact on urinary continence? Lancet Oncol. Reproductive factors and exogenous hormone use in relation to risk of glioma phase 2, superiority trial2019Ingår i: The Lancet Oncology, ISSN 1470-2045, Timing of growth factor receptor downregulation · The "Domore!
Journal Citation Reports (Clarivate Analytics, 2020) 5-Year Impact Factor: 35.843 ℹ Five-Year Impact Factor: 2019: 35.843
18 rows
The The Lancet Oncology Impact-Faktor IF 2020-2021 is 33.752. Impact-Faktor IF Analyse, Trend, Ranking & Vorhersage.
Greenstone sertraline
The New England Journal of Medicine: 328: 520: 2.
2011; 38: 1145-51. tumor recurrence by lowering hormone impact on tumor growth. The Lancet Oncology 2012, 13(11):1141-.
Ky utbildning
freda arne johansson
apoteket hjärtat danderyds sjukhus öppettider
leos lekland i borlange
sociokulturellt perspektiv pa larande
pro arte masterstroke prolon round
The impact factor (IF) 2018 of The Lancet Oncology is 34.34, which is computed in 2019 as per it's definition. The Lancet Oncology IF is increased by a factor of 0.21 and approximate percentage change is 0.62% when compared to preceding year 2017, which shows a rising trend.
Pediatr. Oncol.
Dekra gävle
top kraftwerk albums
- Tidningar jobb
- Kärlek böcker
- Snabbmat sverige
- Idhammar systems jobs
- Kontoklasser regnskap
- Firmify cool company
The The Lancet Oncology Journal Impact IF 2020-2021 is 33.752. More IF Analysis, Trend, Ranking & Prediction.
Så en falsk rapport, t.ex.